Mike Webb

Mike Webb has a diverse work experience, primarily in the pharmaceutical and life sciences industry. Mike has held various leadership roles and served as a board member in multiple companies. Currently, they are a board member at Enveric Biosciences Inc., iQure Pharma Inc., and GMDx. In 2017, they became the Chief Executive Officer and board member of CXL Ophthalmics. Prior to that, they worked as a principal at IntrinsicBio Life Sciences Consulting LLC. Mike has also served as a board member at DeuteRx and as an advisory board member at Wolfe Laboratories, Inc. In addition, they were the President and CEO, as well as a board member, at Tyrogenex, Inc. Mike has also worked as a senior advisor at Johnston Blakely & Co. and as a member of the board of directors at Virtify, Inc.

Mike Webb earned their Bachelor of Arts and Bachelor of Science degrees in Biochemistry and Economics from The University of Kansas, where they studied from 1976 to 1980. Mike then pursued a Master of Arts degree in International Relations at the University of Sussex, attending from 1981 to 1982. Following this, they completed an MBA program at Northwestern University - Kellogg School of Management, specializing in Marketing, Finance, and Healthcare Management, from 1982 to 1984.